Verrica Pharmaceuticals Files 8-K on Security Holder Votes
Ticker: VRCA · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Verrica Pharma held a security holder vote on June 6th. Details filed June 10th.
AI Summary
Verrica Pharmaceuticals Inc. filed an 8-K on June 10, 2024, reporting on matters submitted to a vote of its security holders as of June 6, 2024. The filing details the company's corporate information, including its principal executive offices in West Chester, PA, and its IRS Employer Identification Number.
Why It Matters
This filing indicates that Verrica Pharmaceuticals held a vote of its security holders, which could pertain to significant corporate actions or governance matters that may impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding security holder votes and does not contain information about significant financial distress or operational changes.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Registrant
- June 6, 2024 (date) — Date of earliest event reported
- June 10, 2024 (date) — Date of Report
- West Chester, PA (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Verrica Pharmaceuticals' security holders?
The filing does not specify the exact matters voted upon, only that such matters were submitted for a vote as of June 6, 2024.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 6, 2024.
What is Verrica Pharmaceuticals Inc.'s principal executive office address?
The principal executive offices are located at 44 West Gay Street, Suite 400, West Chester, PA 19380.
What is Verrica Pharmaceuticals Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number is 46-3137900.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 745 words · 3 min read · ~2 pages · Grade level 12 · Accepted 2024-06-10 16:18:31
Filing Documents
- d834681d8k.htm (8-K) — 35KB
- 0001193125-24-158353.txt ( ) — 154KB
- vrca-20240606.xsd (EX-101.SCH) — 3KB
- vrca-20240606_lab.xml (EX-101.LAB) — 18KB
- vrca-20240606_pre.xml (EX-101.PRE) — 11KB
- d834681d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Verrica Pharmaceuticals Inc. Date: June 10, 2024 /s/ P. Terence Kohler, Jr. P. Terence Kohler, Jr. Chief Financial Officer